April 2010
Volume 51, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2010
RhoA Activation Participates in Thrombin-Induced Inhibition of Hemichannel-Responses in Bovine Corneal Endothelial Cells
Author Affiliations & Notes
  • B. J. Himpens
    Physiology, K.U.Leuven, Leuven, Belgium
  • R. Ponsaerts
    Physiology, K.U.Leuven, Leuven, Belgium
  • C. D'hondt
    Physiology, K.U.Leuven, Leuven, Belgium
  • F. Hertens
    Physiology, K.U.Leuven, Leuven, Belgium
  • J. Vereecke
    Physiology, K.U.Leuven, Leuven, Belgium
  • G. Bultynck
    Physiology, K.U.Leuven, Leuven, Belgium
  • Footnotes
    Commercial Relationships  B.J. Himpens, None; R. Ponsaerts, None; C. D'hondt, None; F. Hertens, None; J. Vereecke, None; G. Bultynck, None.
  • Footnotes
    Support  FWO-Vlaanderen G.0545.08, GOA/09/12, IAP program P6/28
Investigative Ophthalmology & Visual Science April 2010, Vol.51, 2833. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      B. J. Himpens, R. Ponsaerts, C. D'hondt, F. Hertens, J. Vereecke, G. Bultynck; RhoA Activation Participates in Thrombin-Induced Inhibition of Hemichannel-Responses in Bovine Corneal Endothelial Cells. Invest. Ophthalmol. Vis. Sci. 2010;51(13):2833. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Thrombin inhibits connexin-hemichannel responses in bovine corneal endothelial cells (BCEC) via PAR-1 activation. This inhibition involves the activation of the actomyosin cytoskeleton by sensitization towards intracellular [Ca2+] and is mediated by enhanced phosphorylation of myosin light chain 2 (MLC). We have previously shown that Rho-associated kinase plays an important role in this MLC-phosphorylation. Here, we investigated the role of RhoA activation in the thrombin-induced hemichannel inhibition in BCEC.

Methods: : RhoA activity was assessed via GST-Rhotekin-RBD protein agarose beads (Cytoskeleton) as well as RhoA G-lisaTM Activation assay (Cytoskeleton). Inhibition of RhoA activity was achieved by pre-treating cells with C3 toxin of Clostridium botulinum. Hemichannel responses were assayed as intercellular Ca2+-wave propagation and ATP release in response to mechanical stimulation (MS) and as LY-dye uptake (2.5 %; 5 min) in response to Ca2+-free medium. MS-induced intercellular Ca2+-wave propagation, mainly driven by Cx43-mediated paracrine signaling, was measured in BCEC loaded with Fluo4-AM and the maximal spreading was quantified (active area). ATP release was measured via a luciferin/luciferase assay.

Results: : Within less than 1 min, treatment of BCEC with thrombin (2U/ml; 5 min) induced a rapid and transient activation of RhoA via a GDP/GTP exchange mechanism. This RhoA activation was prevented by pre-treating the cells with C3 toxin (1 mg/ml; 3 hours). C3 toxin by itself did not affect the hemichannel responses in BCEC. Furthermore, C3 toxin abolished the inhibition of Cx43-hemichannel responses by thrombin in BCEC, as observed in intracellular Ca2+-wave propagation (p<0.001), ATP release (p<0.001) and restored LY-dye uptake.

Conclusions: : RhoA is rapidly and transiently activated upon thrombin treatment of BCEC. Since pharmacological inhibition of Rho-GTPase activity significantly overcomes the inhibitory effects of thrombin, it is likely that RhoA activation is a key player in the thrombin-induced inhibition of Cx43-hemichannel activity in BCEC.

Keywords: cornea: endothelium • cell-cell communication • cytoskeleton 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×